Transcatheter Mitral Valve Replacement - European Reimbursement Report

  • ID: 4243335
  • Report
  • Region: Europe
  • European Med Tech Reimbursement Consulting AB
1 of 4
Essential Information About Reimbursement and National Funding of the Transcatheter Mitral Valve Replacement for Mitral Regurgitation

This report presents a summary of the reimbursement situation for a transcatheter mitral valve replacement for mitral regurgitation.

Report includes essential information about reimbursement and national funding of the transcatheter mitral valve replacement for mitral regurgitation, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland
Note: Product cover images may vary from those shown
2 of 4

1. Introduction and summary

2. Executive summary table

3. Contents

4. Methodology

5. Reimbursement analysis in Austria
5.1. Overview of the reimbursement system
5.2. Reimbursement for transcatheter mitral valve replacement

6. Reimbursement analysis in Belgium
6.1. Overview of the reimbursement system
6.2. Reimbursement for transcatheter mitral valve replacement
6.2.1. Procedure coding
6.2.2. Payment mechanism and reimbursement tariffs

7. Reimbursement analysis in Denmark
7.1. Overview of the reimbursement system
7.2. Reimbursement for transcatheter mitral valve replacement
7.2.1. Procedure coding
7.2.2. Diagnosis coding
7.2.3. Payment mechanism and reimbursement tariffs

8. Reimbursement analysis in England
8.1. Overview of the reimbursement system
8.2. Reimbursement for transcatheter mitral valve replacement
8.2.1. Procedure coding
8.2.2. Diagnosis coding
8.2.3. Payment mechanism and reimbursement tariffs
8.2.4. Policy considerations
8.2.4.1. National commissioning by NHS England
8.2.4.2. Health technology assessment by NICE

9. Reimbursement analysis in France
9.1. Overview of the reimbursement system
9.2. Reimbursement for transcatheter mitral valve replacement

10. Reimbursement analysis in Germany
10.1. Overview of the reimbursement system
10.2. Reimbursement for transcatheter mitral valve replacement
10.2.1. Procedure coding
10.2.2. Diagnosis coding
10.2.3. Payment mechanism and reimbursement tariffs
10.2.4. Policy considerations

11. Reimbursement analysis in Italy
11.1. Overview of the reimbursement system
11.2. Reimbursement for transcatheter mitral valve replacement
11.2.1. Procedure coding at national level
11.2.2. Procedure coding at regional level (Emilia-Romagna region)
11.2.3. Diagnosis coding
11.2.4. Payment mechanism and reimbursement tariffs at national level
11.2.5. Payment mechanism and reimbursement tariffs at regional level

12. Reimbursement analysis in the Netherlands
12.1. Overview of the reimbursement system
12.2. Reimbursement for transcatheter mitral valve replacement
12.2.1. Procedure coding
12.2.2. Material coding
12.2.3. Diagnosis coding
12.2.4. Payment mechanism and reimbursement tariffs
12.2.5. Policy considerations
12.2.6. Health technology assessment by National Healthcare Institute

13. Reimbursement analysis in Norway
13.1. Overview of the reimbursement system
13.2. Reimbursement for transcatheter mitral valve replacement
13.2.1. Procedure coding
13.2.2. Diagnosis coding
13.2.3. Payment mechanism and reimbursement tariffs
13.2.4. Policy considerations

14. Reimbursement analysis in Sweden
14.1. Overview of the reimbursement system
14.2. Reimbursement for transcatheter mitral valve replacement
14.2.1. Procedure coding
14.2.2. Diagnosis coding
14.2.3. Payment mechanism and reimbursement tariffs

15. Reimbursement analysis in Switzerland
15.1. Overview of the reimbursement system
15.2. Reimbursement for transcatheter mitral valve replacement
15.2.1. Procedure coding
15.2.2. Diagnosis coding
15.2.3. Payment mechanism and reimbursement tariffs
15.2.4. Policy considerations
15.2.4.1. Restrictions for percutaneous interventional treatment of severe mitral valve insufficiency in the Health Benefit List

16. Disclaimer

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Caisson Interventional (Caisson Transcatheter Mitral Valve System)
  • Edwards Lifesciences (CardiAQ-Edwards Transcatheter Mitral Valve)
  • HighLife (HighLife transcatheter mitral valve replacement device)
  • Medtronic (TMV)
  • MitrAssist
  • NaviGate Cardiac Structures (NAVI System)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll